Home The Word Brain My Amedeo FAQ Privacy About   

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.

  Vascular Surgery

  Free Subscription

Articles published in Lancet

Retrieve available abstracts of 51 articles:
HTML format

Single Articles

    February 2024
  1. LEE ZS, Ryan N
    Intravascular imaging in percutaneous coronary intervention.
    Lancet. 2024 Feb 21:S0140-6736(23)02686-7. doi: 10.1016/S0140-6736(23)02686.

  2. STONE GW, Christiansen EH, Ali ZA, Andreasen LN, et al
    Intravascular imaging-guided coronary drug-eluting stent implantation: an updated network meta-analysis.
    Lancet. 2024 Feb 21:S0140-6736(23)02454-6. doi: 10.1016/S0140-6736(23)02454.
    PubMed     Abstract available

  3. CONSOLI A, Gory B
    Long-term results of mechanical thrombectomy for large ischaemic stroke.
    Lancet. 2024 Feb 8:S0140-6736(24)00158-2. doi: 10.1016/S0140-6736(24)00158.

  4. SARRAJ A, Abraham MG, Hassan AE, Blackburn S, et al
    Endovascular thrombectomy plus medical care versus medical care alone for large ischaemic stroke: 1-year outcomes of the SELECT2 trial.
    Lancet. 2024 Feb 8:S0140-6736(24)00050-3. doi: 10.1016/S0140-6736(24)00050.
    PubMed     Abstract available

    January 2024
  5. LANDI A, Pedrazzini G, Wild L, Beele A, et al
    Coronary embolisation of native aortic valve debris during transcatheter aortic valve replacement: mechanical embolectomy and histopathological analysis.
    Lancet. 2024;403:e5-e6.

    December 2023
  6. JIMENEZ DIAZ VA, Iniguez Romo A
    Intracoronary artery visualisation of crystalline sirolimus deposits after drug-coated balloon angioplasty for acute coronary syndrome.
    Lancet. 2023;402:2111-2112.

    October 2023
  7. IGLESIAS JF, Roffi M, Losdat S, Muller O, et al
    Long-term outcomes with biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents in ST-segment elevation myocardial infarction: 5-year follow-up of the BIOSTEMI randomised superiority trial.
    Lancet. 2023 Oct 25:S0140-6736(23)02197-9. doi: 10.1016/S0140-6736(23)02197.
    PubMed     Abstract available

  8. BUITEN RA, Ploumen EH
    Drug-eluting stents for ST-segment elevation myocardial infarction: extending the biodegradable versus durable polymer debate.
    Lancet. 2023 Oct 25:S0140-6736(23)02297-3. doi: 10.1016/S0140-6736(23)02297.

  9. DIPPEL DWJ, Roozenbeek B
    Thrombectomy for acute ischaemic stroke without advanced imaging.
    Lancet. 2023 Oct 10:S0140-6736(23)02229-8. doi: 10.1016/S0140-6736(23)02229.

  10. BENDSZUS M, Fiehler J, Subtil F, Bonekamp S, et al
    Endovascular thrombectomy for acute ischaemic stroke with established large infarct: multicentre, open-label, randomised trial.
    Lancet. 2023 Oct 10:S0140-6736(23)02032-9. doi: 10.1016/S0140-6736(23)02032.
    PubMed     Abstract available

    August 2023
    Does thrombolysis add value to thrombectomy for acute ischaemic stroke?
    Lancet. 2023 Aug 25:S0140-6736(23)01202-3. doi: 10.1016/S0140-6736(23)01202.

    May 2023
  12. KALRA A, Kumar A
    Endovascular reperfusion strategy for infra-popliteal chronic limb threatening ischaemia.
    Lancet. 2023;401:1749-1750.

  13. BRADBURY AW, Moakes CA, Popplewell M, Meecham L, et al
    A vein bypass first versus a best endovascular treatment first revascularisation strategy for patients with chronic limb threatening ischaemia who required an infra-popliteal, with or without an additional more proximal infra-inguinal revascularisatio
    Lancet. 2023;401:1798-1809.
    PubMed     Abstract available

    April 2023
  14. GAUDINO M, Andreotti F, Kimura T
    Current concepts in coronary artery revascularisation.
    Lancet. 2023 Apr 27:S0140-6736(23)00459-2. doi: 10.1016/S0140-6736(23)00459.
    PubMed     Abstract available

    Even more benefit with endovascular treatment for patients with acute ischaemic stroke: MR CLEAN-LATE.
    Lancet. 2023;401:1317-1319.

    March 2023
  16. DILETTI R, den Dekker WK, Bennett J, Schotborgh CE, et al
    Immediate versus staged complete revascularisation in patients presenting with acute coronary syndrome and multivessel coronary disease (BIOVASC): a prospective, open-label, non-inferiority, randomised trial.
    Lancet. 2023 Mar 3:S0140-6736(23)00351-3. doi: 10.1016/S0140-6736(23)00351.
    PubMed     Abstract available

  17. PUSTJENS TFS, Vriesendorp PA, Van't Hof AWJ
    Revascularisation in acute coronary syndromes: change in practice?
    Lancet. 2023 Mar 3:S0140-6736(23)00403-8. doi: 10.1016/S0140-6736(23)00403.

    November 2022
  18. YANG P, Song L, Zhang Y, Zhang X, et al
    Intensive blood pressure control after endovascular thrombectomy for acute ischaemic stroke (ENCHANTED2/MT): a multicentre, open-label, blinded-endpoint, randomised controlled trial.
    Lancet. 2022;400:1585-1596.
    PubMed     Abstract available

  19. MISTRY EA, Nguyen TN
    Blood pressure goals after mechanical thrombectomy: a moving target.
    Lancet. 2022;400:1558-1559.

  20. LI Y, Liang Z, Qin L, Wang M, et al
    Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial.
    Lancet. 2022 Nov 4. pii: S0140-6736(22)01999.
    PubMed     Abstract available

    August 2022
  21. GANESAN V, Kartik V, Alex A
    No clubbing in the fingers, only in the toes: patent ductus arteriosus and reversed shunting.
    Lancet. 2022;400:522.

    July 2022
  22. KHATRI P
    Intravenous thrombolysis before thrombectomy for acute ischaemic stroke.
    Lancet. 2022;400:76-78.

  23. MITCHELL PJ, Yan B, Churilov L, Dowling RJ, et al
    Endovascular thrombectomy versus standard bridging thrombolytic with endovascular thrombectomy within 4.5 h of stroke onset: an open-label, blinded-endpoint, randomised non-inferiority trial.
    Lancet. 2022;400:116-125.
    PubMed     Abstract available

  24. FISCHER U, Kaesmacher J, Strbian D, Eker O, et al
    Thrombectomy alone versus intravenous alteplase plus thrombectomy in patients with stroke: an open-label, blinded-outcome, randomised non-inferiority trial.
    Lancet. 2022;400:104-115.
    PubMed     Abstract available

    March 2022
  25. HALLIDAY A, Bulbulia R, Bonati LH, Chester J, et al
    Is stenting equivalent to endarterectomy for asymptomatic carotid stenosis? - Authors' reply.
    Lancet. 2022;399:1116.

  26. ABBOTT AL, Wijeratne T, Zeebregts CJ, Ricco JB, et al
    Is stenting equivalent to endarterectomy for asymptomatic carotid stenosis?
    Lancet. 2022;399:1115-1116.

    Is stenting equivalent to endarterectomy for asymptomatic carotid stenosis?
    Lancet. 2022;399:1114-1115.

    February 2022
  28. ALMEKHLAFI MA, Coutts SB
    Anti-thrombotics cause harm in the setting of stroke thrombectomy.
    Lancet. 2022 Feb 28. pii: S0140-6736(22)00335.

  29. BODEN WE, Kaski JC, Al-Lamee R, Weintraub WS, et al
    What constitutes an appropriate empirical trial of antianginal therapy in patients with stable angina before referral for revascularisation?
    Lancet. 2022;399:691-694.

    November 2021
  30. BELLEY-COTE EP, Devereaux PJ
    PCI versus CABG for left main coronary artery disease: is the jury still out?
    Lancet. 2021 Nov 12. pii: S0140-6736(21)02491.

  31. VAN BOVEN WJ, de Groot JR, Kluin J
    A short cut to prevent postoperative atrial fibrillation.
    Lancet. 2021 Nov 12. pii: S0140-6736(21)02435.

  32. MEHRAN R, Owen R, Chiarito M, Baber U, et al
    A contemporary simple risk score for prediction of contrast-associated acute kidney injury after percutaneous coronary intervention: derivation and validation from an observational registry.
    Lancet. 2021 Nov 12. pii: S0140-6736(21)02326.
    PubMed     Abstract available

  33. SABATINE MS, Bergmark BA, Murphy SA, O'Gara PT, et al
    Percutaneous coronary intervention with drug-eluting stents versus coronary artery bypass grafting in left main coronary artery disease: an individual patient data meta-analysis.
    Lancet. 2021 Nov 12. pii: S0140-6736(21)02334.
    PubMed     Abstract available

  34. JOVIN TG, Nogueira RG, Lansberg MG, Demchuk AM, et al
    Thrombectomy for anterior circulation stroke beyond 6 h from time last known well (AURORA): a systematic review and individual patient data meta-analysis.
    Lancet. 2021 Nov 11. pii: S0140-6736(21)01341.
    PubMed     Abstract available

  35. DIPPEL D, Roozenbeek B
    Late thrombectomy for ischaemic stroke.
    Lancet. 2021 Nov 11. pii: S0140-6736(21)02097.

  36. KANG J, Koo BK, Park KW, Shin ES, et al
    Aspirin versus clopidogrel after percutaneous coronary intervention - Authors' reply.
    Lancet. 2021;398:1685-1686.

  37. PAREEK M, Byrne C
    Aspirin versus clopidogrel after percutaneous coronary intervention.
    Lancet. 2021;398:1685.

  38. XU B, Tu S, Song L, Jin Z, et al
    Angiographic quantitative flow ratio-guided coronary intervention (FAVOR III China): a multicentre, randomised, sham-controlled trial.
    Lancet. 2021 Nov 3. pii: S0140-6736(21)02248.
    PubMed     Abstract available

    October 2021
  39. KIM CJ, Park MW, Kim MC, Choo EH, et al
    Unguided de-escalation from ticagrelor to clopidogrel in stabilised patients with acute myocardial infarction undergoing percutaneous coronary intervention (TALOS-AMI): an investigator-initiated, open-label, multicentre, non-inferiority, randomised tr
    Lancet. 2021;398:1305-1316.
    PubMed     Abstract available

    September 2021
  40. TULAMO R, Venermo M
    Intervention for asymptomatic carotid artery stenosis.
    Lancet. 2021;398:1025-1027.

    August 2021
  41. HALLIDAY A, Bulbulia R, Bonati LH, Chester J, et al
    Second asymptomatic carotid surgery trial (ACST-2): a randomised comparison of carotid artery stenting versus carotid endarterectomy.
    Lancet. 2021 Aug 27. pii: S0140-6736(21)01910.
    PubMed     Abstract available

    July 2021
  42. MOSS JG, Wu O, Bodenham AR, Agarwal R, et al
    Central venous access devices for the delivery of systemic anticancer therapy (CAVA): a randomised controlled trial.
    Lancet. 2021;398:403-415.
    PubMed     Abstract available

  43. TAXBRO K, Chopra V
    Appropriate vascular access for patients with cancer.
    Lancet. 2021;398:367-368.

    May 2021
  44. KOO BK, Kang J, Park KW, Rhee TM, et al
    Aspirin versus clopidogrel for chronic maintenance monotherapy after percutaneous coronary intervention (HOST-EXAM): an investigator-initiated, prospective, randomised, open-label, multicentre trial.
    Lancet. 2021 May 14. pii: S0140-6736(21)01063.
    PubMed     Abstract available

  45. AZIZI M, Sanghvi K, Saxena M, Gosse P, et al
    Ultrasound renal denervation for hypertension resistant to a triple medication pill (RADIANCE-HTN TRIO): a randomised, multicentre, single-blind, sham-controlled trial.
    Lancet. 2021 May 14. pii: S0140-6736(21)00788.
    PubMed     Abstract available

    April 2021
  46. GALLI M, Benenati S, Capodanno D, Franchi F, et al
    Guided versus standard antiplatelet therapy in patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis.
    Lancet. 2021;397:1470-1483.
    PubMed     Abstract available

  47. SIBBING D, Kastrati A
    Guided P2Y12 inhibitor therapy after percutaneous coronary intervention.
    Lancet. 2021;397:1423-1425.

  48. RICKARD CM, Marsh NM, Larsen EN, McGrail MR, et al
    Effect of infusion set replacement intervals on catheter-related bloodstream infections (RSVP): a randomised, controlled, equivalence (central venous access device)-non-inferiority (peripheral arterial catheter) trial.
    Lancet. 2021;397:1447-1458.
    PubMed     Abstract available

    March 2021
    The risk of no risk in STEMI.
    Lancet. 2021;397:1039-1040.

  50. FIGTREE GA, Vernon ST, Hadziosmanovic N, Sundstrom J, et al
    Mortality in STEMI patients without standard modifiable risk factors: a sex-disaggregated analysis of SWEDEHEART registry data.
    Lancet. 2021;397:1085-1094.
    PubMed     Abstract available

    October 2020
  51. TAKAHASHI K, Serruys PW, Fuster V, Farkouh ME, et al
    Redevelopment and validation of the SYNTAX score II to individualise decision making between percutaneous and surgical revascularisation in patients with complex coronary artery disease: secondary analysis of the multicentre randomised controlled SYNT
    Lancet. 2020 Oct 8. pii: S0140-6736(20)32114.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Vascular Surgery is free of charge.